On Sept. 18, the vaccine advisory committee for the Centers for Disease Control and Prevention voted to change its recommendation on the combined vaccine for chickenpox and measles, mumps and rubella, called the MMRV vaccine. We spoke to experts about claims made at the meeting as well as the implications of the vote.
Q&A on Changes to Recommendations for Combined MMR and Chickenpox Vaccine
